ICG-guided lymphadenectomy in left-sided colorectal cancer Cancer
Conditions
Interventions
• ICG-Guided Group (Experimental Arm): Patients received real-time indocyanine green (ICG) near-infrared fluorescence imaging-guided central lymph nodes mapping and dissection during laparoscopic radi
Sponsors
Peking University People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 85 years 2. Pathologically confirmed left-sided colon or rectal adenocarcinomas 3. Legal competence
Exclusion criteria
Exclusion criteria: 1. Coexisting untreated malignancies 2. Medically contraindications to laparoscopic surgery 3. Known allergy to ICG or iodine 4. Impaired liver function
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Total number of lymph nodes retrieved, measured via pathological analysis (postoperative day 0) 2. Surgical safety, assessed by intraoperative and postoperative complication rate within 30 days, based on clinical records and follow-up visits 3. 3-year disease-free survival (DFS), measured by clinical and radiological follow-up at regular intervals (every 3–6 months) 4. 3-year overall survival (OS), assessed through hospital records and follow-up calls at 36 months | — |
Primary
| Measure | Time frame |
|---|---|
| Number of central lymph nodes harvested, measured by pathological examination of surgical specimens postoperatively at day 0 | — |
Countries
China
Contacts
Public ContactYudi Bao
Outcome results
None listed